Editorial: Advancing Genomics for Rare Disease Diagnosis and Therapy Development

Frontiers in Pharmacology

Ruth Roberts¹  Tieliu Shi³  Zhichao Liu³  Weida Tong³  Mike Mikailov⁴ 

[1] Department of Biosciences, University of Birmingham, Birmingham, United Kingdom;Department of Drug Safety, ApconiX, Alderley Edge, United Kingdom;Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, United States;Office of Science and Engineering Labs, Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, United States;

关键词: rare dieases;    NGS;    genomics;    diagnosis;    drug discovery;   

DOI  :  10.3389/fphar.2020.598889

来源: DOAJ

【 授权许可】

Unknown